Launch week offerEnds in00h00m00s

annual Promonthly Pro

Nallakkandi Rajeevan

Senior Research Scientist

Yale University

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States

Articles (14)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

James Hyman

Assistant Professor

University of Nevada

UNITED STATES

View details

Elizabeth Viglianti

University of Michigan

UNITED STATES

View details

Thomas Osborne

Clinical Associate Professor (affiliated)

Stanford University School of Medicine

UNITED STATES

View details

Leyuan Xu

Assistant Professor

Yale University

UNITED STATES

View details

Chrysoula Kitsou

Assistant Research Professor

University of Maryland

UNITED STATES

View details

Tim B. Bigdeli

SUNY Downstate Health Sciences University

UNITED STATES

View details

Juan Anguita

Ikerbasque Professor

SPAIN

View details

Jaroslav Bendl

Assistant Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Roseann Peterson

Associate Professor

UNITED STATES

View details

Jonathan Oliver

Associate Professor

University of Minnesota

UNITED STATES

View details

Denise Hynes

Oregon State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nallakkandi Rajeevan

Research Interests

Make your next move.

Explore related searches

Articles (14)

Biological insights into schizophrenia from ancestrally diverse populations

Oseltamivir for Treatment of Influenza Among Outpatient Veterans: Target Trial Emulation

Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up

Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interaction.

High dimensional predictions of suicide risk in 4.2 million US Veterans using ensemble transfer learning

Correlates of suicidal behaviors and genetic risk among United States veterans with schizophrenia or bipolar I disorder.

Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients-March 2022-April 2023

Identifying Veterans Who Benefit from Nirmatrelvir-Ritonavir: A Target Trial Emulation

Metformin prescription for U.S. veterans with prediabetes, 2010–2019

Dome1–JAK–STAT signaling between parasite and host integrates vector immunity and development

Effectiveness of COVID-19 Treatment With Nirmatrelvir–Ritonavir or Molnupiravir Among U.S. Veterans: Target Trial Emulation Studies With One-Month and Six-Month Outcomes

Anti-SARS-CoV-2 Pharmacotherapies Among Nonhospitalized US Veterans, January 2022 to January 2023

Effectiveness of Nirmatrelvir–Ritonavir Against the Development of Post–COVID-19 Conditions Among U.S. Veterans

Modeling the longitudinal changes of ancestry diversity in the Million Veteran Program

Collaborators (11)

James Hyman

Elizabeth Viglianti

Thomas Osborne

Leyuan Xu

Chrysoula Kitsou

Tim B. Bigdeli

Juan Anguita

Jaroslav Bendl

Roseann Peterson

Jonathan Oliver

Denise Hynes

Make your next move.